Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Acta Neurochirurgica
|
November 10, 2012
Unusual clinico-pathological features in primary Hodgkin's lymphomas of the central nervous system
Marco Gessi, Klaus Kuchelmeister, Udo Kellner, et al.
Journal of Cancer Research and Clinical Oncology
|
October 29, 2024
Challenges in the treatment of soft-tissue plasmacytoma: a retrospective analysis of 120 patients with extramedullary multiple myeloma
Dominik Zolnowski, Simone Karp, Paul Warncke, et al.
Cancer Management and Research
|
March 26, 2026
Haploidentical Allogeneic Cell Transplantation in Relapsed/Refractory Multiple Myeloma
Julia Frimmel, Anke Morgner, Claudia Brogsitter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 16, 2019
Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma
Frederick Fasslrinner, Friedrich Stölzel, Michael Kramer, et al.
Annals of Hematology
|
February 25, 2025
Is there still a place for autologous salvage transplantation in relapsed/refractory multiple myeloma in the era of novel therapies?
Simone Karp, Karolin Trautmann-Grill, Paul Warncke, et al.
Haematologica
|
January 10, 2013
Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation
Elisabeth Schorb, Benjamin Kasenda, Johannes Atta, et al.
Cancer Management and Research
|
February 25, 2022
Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse
Katja Sockel, Friedrich Stölzel, Franziska Hönl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 22, 2017
Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial
Jan Moritz Middeke, Regina Herbst, Stefani Parmentier, et al.
Blood Advances
|
July 8, 2020
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
Linus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Blood Advances
|
July 8, 2020
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
Linus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Acta Neurochirurgica
|
November 10, 2012
Unusual clinico-pathological features in primary Hodgkin's lymphomas of the central nervous system
Marco Gessi, Klaus Kuchelmeister, Udo Kellner, et al.
Journal of Cancer Research and Clinical Oncology
|
October 29, 2024
Challenges in the treatment of soft-tissue plasmacytoma: a retrospective analysis of 120 patients with extramedullary multiple myeloma
Dominik Zolnowski, Simone Karp, Paul Warncke, et al.
Cancer Management and Research
|
March 26, 2026
Haploidentical Allogeneic Cell Transplantation in Relapsed/Refractory Multiple Myeloma
Julia Frimmel, Anke Morgner, Claudia Brogsitter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 16, 2019
Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma
Frederick Fasslrinner, Friedrich Stölzel, Michael Kramer, et al.
Annals of Hematology
|
February 25, 2025
Is there still a place for autologous salvage transplantation in relapsed/refractory multiple myeloma in the era of novel therapies?
Simone Karp, Karolin Trautmann-Grill, Paul Warncke, et al.
Haematologica
|
January 10, 2013
Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation
Elisabeth Schorb, Benjamin Kasenda, Johannes Atta, et al.
Cancer Management and Research
|
February 25, 2022
Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse
Katja Sockel, Friedrich Stölzel, Franziska Hönl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 22, 2017
Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial
Jan Moritz Middeke, Regina Herbst, Stefani Parmentier, et al.
Blood Advances
|
July 8, 2020
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
Linus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Blood Advances
|
July 8, 2020
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
Linus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Page
of 2